These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2563091)

  • 1. Hepatotoxicity of actinomycin-D.
    Pritchard J; Raine J; Wallendszus K
    Lancet; 1989 Jan; 1(8630):168. PubMed ID: 2563091
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatotoxicity and actinomycin D.
    Lancet; 1990 May; 335(8700):1290. PubMed ID: 1971368
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatotoxicity with actinomycin D.
    D'Angio GJ
    Lancet; 1987 Jul; 2(8550):104. PubMed ID: 2885556
    [No Abstract]   [Full Text] [Related]  

  • 4. [Veno-occlusive disease of the liver and nephroblastoma in children (role of the vincristine-actinomycin combination?].
    Chevallier B; Treluyer JM; Devictor D; Yaiche MC; Lagardère B
    Ann Pediatr (Paris); 1988 Sep; 35(7):525-6. PubMed ID: 2460015
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatotoxicity of chemotherapy following nephrectomy and radiation therapy for right-sided Wilms tumor.
    Jayabose S; Shende A; Lanzkowsky P
    J Pediatr; 1976 May; 88(5):898. PubMed ID: 178848
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatopathy-thrombocytopenia syndrome after actinomycin-D therapy: treatment with defibrotide.
    Martín-Lázaro JF; Palanca D; Garcia-Iñiguez JP; Madurga P; Carboné A
    Pediatr Hematol Oncol; 2013 Feb; 30(1):25-7. PubMed ID: 23216129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unexpected toxicity encountered in the National Wilms' Tumor Study.
    D'Angio GJ
    Cancer Treat Rep; 1987 Oct; 71(10):993. PubMed ID: 2820573
    [No Abstract]   [Full Text] [Related]  

  • 8. A report of an actinomycin D study group in Japan.
    Takatsu T
    Paediatr Univ Tokyo; 1970 Jan; 17():7-9. PubMed ID: 4315852
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatopathy-Thrombocytopenia Syndrome During Actinomycin D Treatment May Be Related to MDR1 (ABCB1) Gene Polymorphisms.
    Baskin Y; Amirfallah A; Calibasi G; Olgun N
    Am J Ther; 2016; 23(2):e594-6. PubMed ID: 24413370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatopathy-thrombocytopenia syndrome (HTS) after actinomycin-D therapy: report of three cases and review of the literature.
    Farruggia P; Macaluso A; Tropia S; Di Marco F; Russo D; Grigoli A; Trizzino A; D'Angelo P
    Pediatr Hematol Oncol; 2011 Apr; 28(3):237-43. PubMed ID: 21271778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Actinomycin D-induced hepatotoxicity.
    White L; Tobias V; Hughes DW
    Pediatr Hematol Oncol; 1989; 6(1):53-7. PubMed ID: 2561915
    [No Abstract]   [Full Text] [Related]  

  • 12. Severe hepatic toxicity after treatment with vincristine and dactinomycin using single-dose or divided-dose schedules: a report from the National Wilms' Tumor Study.
    Green DM; Norkool P; Breslow NE; Finklestein JZ; D'Angio GJ
    J Clin Oncol; 1990 Sep; 8(9):1525-30. PubMed ID: 2167951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatopathy-thrombocytopenia syndrome--a complication of dactinomycin therapy for Wilms' tumor: a report from the United Kingdom Childrens Cancer Study Group.
    Raine J; Bowman A; Wallendszus K; Pritchard J
    J Clin Oncol; 1991 Feb; 9(2):268-73. PubMed ID: 1846405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective thrombocytopenia in children with Wilms tumor: an immune-mediated effect of dactinomycin?
    Shannon A; Smith J; Nagel K; Levesque R; Warkentin T; Barr R
    Med Pediatr Oncol; 2003 Nov; 41(5):483-5. PubMed ID: 14515398
    [No Abstract]   [Full Text] [Related]  

  • 15. Dactinomycin.
    Med Lett Drugs Ther; 1965 May; 7(11):41-2. PubMed ID: 4283937
    [No Abstract]   [Full Text] [Related]  

  • 16. Single versus multiple dose dactinomycin therapy of Wilms's tumor. A controlled co-operative study conducted by the Children's Cancer Study Group A (formerly Acute Leukemia Co-operative Chemotherapy Group A).
    Wolff JA; Newton WA; Krivit W; D'Angio GJ
    N Engl J Med; 1968 Aug; 279(6):290-4. PubMed ID: 4298260
    [No Abstract]   [Full Text] [Related]  

  • 17. [Veno-occlusive disease of the liver as a treatment complication in children with Wilm's tumor].
    Zoubek A; Wiesbauer P; Pracher E; Martins da Cunha AC; Emminger W; Grois N; Gadner H
    Padiatr Padol; 1992; 27(2):47-50. PubMed ID: 1318536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wilms' tumour: adjuvant treatment with actinomycin D and vincristine.
    Jenkin RD; Jeffs RD; Stephens CA; Sonley MJ
    Can Med Assoc J; 1976 Jul; 115(2):136-40. PubMed ID: 179690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: a report from the National Wilms' Tumor Study Group.
    Green DM; Breslow NE; Beckwith JB; Finklestein JZ; Grundy PE; Thomas PR; Kim T; Shochat SJ; Haase GM; Ritchey ML; Kelalis PP; D'Angio GJ
    J Clin Oncol; 1998 Jan; 16(1):237-45. PubMed ID: 9440748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term evaluation of single versus multiple courses of actinomycin D therapy of Wilms's tumor.
    Wolff JA; D'Angio G; Hartmann J; Krivit W; Newton WA
    N Engl J Med; 1974 Jan; 290(2):84-6. PubMed ID: 4357042
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.